

Has your ownership in a Turkish company been diluted through a capital increase? Learn how foreign minority shareholders can challenge abusive dilution, protect pre-emptive rights, contest corporate resolutions and seek compensation.
A foreign investor may establish or acquire shares in a Turkish company with a significant ownership percentage and later discover that their stake has been dramatically reduced following a capital increase.
An investor who originally owned 40% may suddenly own 20%, 10% or even less because new shares were issued and acquired primarily by the controlling shareholder or another investor.
Not every dilution is unlawful.
Companies legitimately need additional capital to finance expansion, cover investment requirements, strengthen their balance sheets or respond to financial difficulties. If an existing shareholder chooses not to participate in a lawful capital increase, the mathematical result may be a reduction in that shareholder’s percentage ownership.
However, the position becomes very different where a capital increase is structured primarily to weaken a foreign minority shareholder, transfer corporate control to another shareholder, exclude the investor from future profits or force the investor to sell their remaining interest at a reduced value.
Turkish company law contains important protections against such practices.
The Ministry of Trade confirms that, in a joint-stock company capital increase, each shareholder generally has the right to acquire newly issued shares in proportion to their existing percentage of the company’s capital. Restriction or removal of this pre-emptive right requires justified grounds and at least 60% affirmative approval of the share capital. Management must also explain the reasons for restricting or removing the right in a report, and shareholders must normally receive at least 15 days to exercise their pre-emptive rights. (https://ticaret.gov.tr)
For a foreign minority investor, these protections can be crucial.
Dilution occurs when the company issues additional shares or capital interests and an existing investor’s percentage ownership decreases because the investor does not acquire a proportionate amount of the newly issued equity.
Suppose a foreign investor owns 30 out of 100 shares.
The investor therefore owns 30% of the company.
If the company issues another 100 shares and all of those shares are acquired by the majority shareholder, the foreign investor still owns 30 shares, but now there are 200 shares in total.
The investor’s percentage has fallen from 30% to 15%.
That is dilution.
The important legal question is whether that dilution resulted from a legitimate and properly implemented capital increase or from an abusive corporate strategy designed to disadvantage the minority investor.
No.
A reduction in percentage ownership is not automatically unlawful.
If the company genuinely needs new capital, follows the required corporate procedures and respects the shareholder’s applicable rights, the investor may need to contribute additional capital to preserve the existing ownership percentage.
The Ministry of Trade confirms that capital increases constitute amendments to the articles and are subject to statutory procedures, including corporate resolutions, registration and publication requirements. (https://ticaret.gov.tr)
Therefore, the fact that a foreign shareholder’s percentage decreased is only the beginning of the legal analysis.
The purpose, procedure and economic structure of the capital increase must be investigated.
For joint-stock companies, the pre-emptive right is one of the most important protections against dilution.
The Ministry of Trade explains that every shareholder has the right to acquire newly issued shares according to their existing proportion of the company’s capital. (https://ticaret.gov.tr)
This means that if a foreign investor owns 25% of a company, the starting principle is that the investor should have the opportunity to participate proportionately in a new issuance and thereby preserve that percentage.
The controlling shareholder should not ordinarily be able simply to issue all new shares to themselves while ignoring the minority shareholder’s statutory rights.
Assume a foreign investor owns 40% and the local partner owns 60%.
The company decides to double its capital.
If the foreign shareholder is properly allowed to participate proportionately, the investor can subscribe for the appropriate part of the new capital and maintain the 40% ownership position.
If the foreign investor declines to participate, dilution may result.
But suppose the majority shareholder deliberately prevents the investor from participating and acquires the entire capital increase personally.
The investor’s percentage falls dramatically.
That situation requires immediate investigation.
Yes, but not arbitrarily.
The Ministry of Trade states that pre-emptive rights may be restricted or removed only where justified reasons exist and with at least 60% affirmative approval of the share capital. (https://ticaret.gov.tr)
This is a significant protection for minority investors.
The majority shareholder should not be able to remove pre-emptive rights merely because dilution would make it easier to control the company.
There is another important safeguard.
The Ministry of Trade explains that the board must prepare a report setting out the reasons for restricting or removing pre-emptive rights, the reasons for issuing new shares with or without a premium and how any premium was calculated. The report is subject to registration and publication. (https://ticaret.gov.tr)
This documentation can become extremely important in litigation.
A foreign investor challenging dilution should obtain the report and compare its stated reasons with what actually occurred.
Whether a reason is legally sufficient depends on the circumstances.
A company may have genuine strategic or financing reasons for bringing in a new investor or structuring a particular capital transaction.
But the explanation should withstand scrutiny.
If management says the restriction was necessary to obtain strategic financing, the investor should examine who provided the financing, what the company received and why existing shareholders could not participate.
If the supposed “strategic investor” is actually a company controlled by the majority shareholder, the transaction deserves much closer examination.
Consider a foreign investor owning 35%.
The local partner owns 65%.
Relations deteriorate.
Shortly afterward, the local partner causes the company to approve a very large capital increase and restricts the foreign investor’s ability to acquire the new shares.
The local partner or a related company then acquires almost all of the new equity.
After completion:
Foreign investor: 8%
Local partner and related entities: 92%.
The timing, economic justification, corporate procedure, pre-emptive rights and relationship between the subscribers should all be investigated.
A capital increase should not be assumed legitimate merely because the majority shareholder obtained enough votes to approve it.
This can be a major issue.
The investor should immediately obtain the general assembly notice, agenda, meeting minutes, attendance list, capital increase resolution, amendments to the articles and relevant registration documents.
Determine where notices were sent.
Check whether the company’s records contained the investor’s correct address.
If electronic notification mechanisms were applicable, examine those records as well.
The investor should reconstruct precisely how the capital increase was approved without their participation.
Failure to attend does not automatically invalidate the resolution.
The question becomes whether the meeting was properly called, whether the shareholder had an opportunity to participate and whether the resolution itself complied with applicable law and the company’s constitutional documents.
Foreign residence does not automatically provide grounds to disregard corporate decisions.
Conversely, living abroad should not be exploited as a practical method of excluding an investor.
Preserve the notice records.
Determine what address the company was officially entitled or required to use and whether management knew the investor’s current contact information.
If management intentionally used obsolete information to prevent participation, that evidence may become relevant to a broader allegation of abusive corporate conduct.
That may be true.
A genuine financing need can support a capital increase.
The foreign investor should therefore examine the company’s financial position rather than assuming the explanation is false.
Request financial statements, cash-flow information, debts, bank balances and the board’s explanation for the required capital.
Then ask another question:
Why was the transaction structured in a manner that diluted the minority shareholder?
A legitimate need for financing does not necessarily justify every method used to obtain it.
The size of the capital increase can be significant.
Suppose a company needs approximately EUR 300,000 in additional financing but approves an economically unexplained capital increase equivalent to several million euros, knowing that the foreign minority investor cannot participate.
The relationship between the company’s genuine funding requirements and the size of the increase should be investigated.
An unusually large capital increase is not automatically unlawful, but the commercial justification matters.
Pricing can also be critical.
If a valuable and profitable company issues new shares at a price that substantially benefits the majority shareholder or a connected party, dilution can affect more than voting percentages.
Economic value may effectively shift from existing shareholders to the subscriber.
The investor should therefore examine the nominal value, any issue premium, company valuation and the method used to calculate the subscription price.
The Ministry of Trade specifically notes that the board’s report must explain why new shares are issued with or without a premium and how the premium is calculated where pre-emptive rights are restricted or removed. (https://ticaret.gov.tr)
The mere involvement of a related company does not automatically invalidate a capital increase.
However, it can be highly relevant.
The investor should identify the beneficial ownership of the subscriber and any connection with existing shareholders, directors or managers.
If the majority shareholder claims that an “independent investor” had to receive the new shares, but the investor is actually controlled by the majority shareholder’s family or corporate group, the stated justification should be scrutinized carefully.
The Ministry of Trade states that the board determines the principles governing exercise of the right and must provide shareholders at least 15 days to exercise their pre-emptive rights. The relevant decision is registered and announced. (https://ticaret.gov.tr)
This requirement is highly relevant for foreign investors.
A company should not create an unrealistically short window designed to make participation impossible.
The specific facts matter.
The statutory exercise period, notices received, banking arrangements and communications with company management should be preserved.
If the investor was properly given the required opportunity but simply failed to arrange financing, the legal position may differ substantially from a case where management obstructed payment or provided misleading instructions.
Document the attempted subscription immediately.
Preserve emails, payment instructions, bank transfer attempts and communications with directors or managers.
If the investor validly exercises pre-emptive rights but management refuses the subscription and allocates the shares elsewhere, the evidentiary record can become extremely important.
Potentially.
General assembly resolutions that violate legislation, the articles of association or applicable corporate principles may be subject to judicial challenge under the relevant provisions of Turkish company law.
The correct remedy depends on the nature of the defect.
Some resolutions may be subject to an annulment action, while exceptionally serious defects can raise different questions concerning invalidity.
The investor should not assume all defective resolutions are treated identically.
Corporate-resolution litigation is particularly sensitive to time limits.
A foreign shareholder who discovers dilution should therefore obtain the relevant resolutions immediately and determine when they were adopted.
Do not spend months negotiating with the controlling shareholder before checking whether a statutory challenge period is running.
The date on which the investor discovered the transaction does not necessarily determine every applicable corporate deadline.
The capital increase process includes registration and publication components. The Ministry of Trade states that the capital increase resolution is registered and announced, and that if the increase is not registered within three months of the relevant general assembly or board resolution, the resolution and any required approval lose effect. (https://ticaret.gov.tr)
Where the underlying resolution is disputed, the consequences for registered corporate information should also be examined.
However, challenging the registry entry and challenging the underlying corporate decision are not necessarily the same procedural issue.
Potentially.
This can become particularly important before the capital increase is fully implemented or before the new shareholder uses the resulting voting power.
Suppose the foreign investor’s stake is about to fall from 45% to 5%, and the new controlling shareholder intends immediately to replace the board and sell significant company assets.
Waiting for a final judgment could leave the investor with a technically successful lawsuit but a commercially damaged company.
Where the applicable procedural requirements are met, interim judicial protection should therefore be assessed quickly.
Percentage reduction is not merely mathematical.
It can fundamentally alter voting power.
Consider an investor holding 50%.
After dilution, the investor holds 20%.
The other shareholder now possesses 80%.
The investor may have lost practical influence over management appointments, amendments to corporate documents and other important decisions.
The economic and governance consequences should therefore be examined together.
Some ownership percentages provide practical or statutory influence over decisions requiring enhanced voting thresholds.
A shareholder may therefore lose much more than the numerical percentage appearing on the share certificate.
Reducing an investor below a significant voting threshold can eliminate the ability to block certain corporate decisions.
If a capital increase appears deliberately designed to produce exactly that result, the transaction deserves careful legal scrutiny.
Minority-protection analysis is not limited to pre-emptive rights.
Turkish company law also recognizes the principle that shareholders in equivalent circumstances should receive equal treatment.
A capital transaction designed to benefit one shareholder while imposing an unjustified disadvantage on another may therefore require analysis beyond the mechanical voting requirements for a capital increase.
Corporate power should be exercised for legitimate company purposes rather than simply as a weapon in a shareholder conflict.
This can materially strengthen the company’s position.
Suppose every shareholder was properly informed, received proportionate subscription rights and had the same legally compliant period to participate.
The foreign investor declined to invest additional capital.
The investor’s resulting dilution may be a legitimate economic consequence of that decision.
Minority protection does not necessarily guarantee that an investor can maintain the same percentage indefinitely without participating in future capital requirements.
This alone does not automatically make the capital increase unlawful.
A company may genuinely require new equity.
The law does not necessarily require other shareholders to abandon legitimate financing merely because one investor cannot contribute.
The relevant question is whether the transaction had a legitimate company purpose and whether applicable shareholder protections were respected.
That allegation requires evidence.
Examine the company’s actual funding needs, financial statements, planned investments and financing alternatives.
Compare those figures with the size and structure of the capital increase.
Communications showing an intention to “dilute,” “remove” or “force out” the foreign shareholder may be especially relevant.
Foreign investors should review the shareholder agreement immediately.
It may contain anti-dilution provisions, reserved matters, veto rights, pre-emptive rights, consent requirements, valuation mechanisms or contractual restrictions on issuing new equity.
These protections can exist alongside statutory company-law rights.
A capital increase may therefore comply with one corporate requirement while simultaneously breaching contractual obligations owed to the foreign investor.
Sophisticated investment agreements often include anti-dilution protection.
The exact clause matters.
Some provisions require unanimous or supermajority consent for new share issuances.
Others provide economic adjustments if new shares are issued below an agreed valuation.
Still others require existing investors to be offered the opportunity to maintain their percentage ownership.
Contractual drafting can therefore significantly affect the available remedies.
The corporate validity of the resolution and contractual liability should be analyzed separately.
A breach of the shareholder agreement does not automatically answer every corporate-law question.
Likewise, formal corporate compliance does not necessarily eliminate a contractual damages claim.
Foreign investors should therefore avoid treating the articles of association and shareholder agreement as interchangeable documents.
Potentially, where the statutory requirements for management liability are established.
If directors knowingly participate in a transaction that breaches duties and causes legally recoverable damage, director liability may need to be considered separately from the challenge to the capital increase.
The investor should identify which directors proposed, approved or implemented the transaction and what information was available to them.
Potentially, depending on the corporate structure and conduct involved.
Particularly where the company forms part of a corporate group or control is exercised in a legally significant manner, additional rules concerning controlling enterprises and abuse of control may require consideration.
A majority shareholder’s ability to vote does not create unlimited authority to extract value from minority investors.
Potentially.
But the investor must identify the actual loss.
The reduction in percentage ownership may be relevant, but damages should not be calculated mechanically.
The company’s value before and after the transaction, subscription price, value transferred through the issuance and any direct contractual rights may all require examination.
Expert valuation may be necessary.
Suppose a company is genuinely worth EUR 10 million.
A foreign shareholder owns 30%, giving the stake an indicative proportional value of EUR 3 million before considering minority discounts or other valuation factors.
New shares are then issued disproportionately to the majority shareholder at a price far below the company’s economic value.
The foreign investor’s ownership falls substantially.
The investor may argue not only that voting power was diluted but that economic value was shifted through the pricing of the new issuance.
A proper valuation analysis becomes essential.
As with other corporate disputes, the investor must identify who suffered the legally relevant damage.
Some transactions may damage the company itself.
Others may directly violate rights belonging to the shareholder.
The correct claimant and remedy depend on that distinction.
A foreign investor should not automatically multiply the company’s alleged loss by their ownership percentage and treat that number as personal damages.
The investor should obtain the capital increase resolution, general assembly notices and minutes, attendance records, amended articles, board reports, pre-emptive-right notices, subscription documents, registry records, shareholder agreement and financial materials explaining why additional capital was allegedly required.
Communications with the majority shareholder can be especially important.
If the investor was told in writing that the purpose was to reduce their ownership or force them out, preserve the original communications.
Financial information can test the stated justification.
If management says the company urgently needed EUR 5 million, the investor should examine whether that claim is supported by the company’s cash position, debts, investment plans and operating requirements.
A capital increase motivated by genuine financial necessity looks very different from one created immediately after a shareholder dispute with no clear commercial explanation.
Identify the subscribers.
Determine when payment occurred and from which accounts.
Where possible through lawful procedures, examine whether the majority shareholder genuinely funded the subscription or whether company resources were indirectly used to finance acquisition of the newly issued equity.
The economic substance of the transaction can matter as much as its formal documentation.
Legal remedies may still exist, but the situation becomes more complicated.
The investor should determine when the resolution was adopted, when registration occurred and what subsequent corporate actions have taken place.
Do not assume that completion of registration makes the transaction permanently immune from challenge.
At the same time, do not assume that every completed capital increase can simply be reversed.
The precise legal defect and applicable deadlines must be identified.
Obtain the subsequent resolutions.
If the allegedly abusive capital increase created the voting power used to replace directors or managers, those later decisions may also require examination.
The investor should reconstruct the sequence:
capital increase,
dilution,
change of voting control,
management replacement,
asset transactions.
This chronology can reveal the true commercial significance of the disputed transaction.
This increases urgency substantially.
The foreign shareholder may ultimately restore certain corporate rights but find that the company itself has lost most of its value.
Where the new majority is using its control to transfer important assets, enter related-party transactions or move business elsewhere, emergency protective remedies should be assessed separately from the capital increase challenge.
Assume a foreign investor owns 40% of a Turkish joint-stock company.
After relations with the local 60% shareholder deteriorate, the company calls a general assembly to approve a major capital increase.
The foreign investor later discovers that their pre-emptive rights were restricted and almost all newly issued shares were acquired by an entity associated with the majority shareholder.
The foreign investor’s ownership falls to 8%.
The investor should immediately obtain the capital increase resolution, meeting records, board report explaining the restriction of pre-emptive rights, subscription documents and evidence concerning the identity of the new subscriber.
The Ministry of Trade confirms that every shareholder generally possesses a proportionate right to acquire newly issued shares and that restricting or removing that right requires justified grounds and at least 60% affirmative approval of the capital. Management must explain the reasons for the restriction and the pricing of the new shares in a report. (https://ticaret.gov.tr)
The investor should therefore investigate whether the stated justification was genuine and whether the corporate procedure complied with those protections.
If an imminent management change or asset transaction threatens additional damage, interim protection should be considered without waiting for the entire dispute to reach a final judgment.
The first step is to establish the shareholder’s percentage immediately before and after the disputed transaction. Next, obtain the complete capital increase file, including the resolution, meeting notices, attendance records, board reports, amendments, pre-emptive-right documentation, subscription documents and registration information.
The company’s stated need for capital should then be tested against its actual financial position.
The investor should identify exactly who subscribed for the new equity and whether that person or entity is connected with the controlling shareholder.
Any shareholder agreement should be reviewed for anti-dilution provisions, reserved matters, veto rights and additional subscription protections.
Finally, litigation deadlines and the possibility of interim judicial protection should be assessed immediately, particularly if the new ownership structure is already being used to change management or dispose of company assets.
Yes. A lawful capital increase can reduce an investor’s percentage if the shareholder does not participate proportionately. Dilution is not automatically unlawful.
As a general rule, yes. The Ministry of Trade confirms that each shareholder has the right to acquire newly issued shares proportionately to their existing capital participation. (https://ticaret.gov.tr)
Not arbitrarily. Restriction or removal requires justified grounds and at least 60% affirmative approval of the capital under the framework summarized by the Ministry of Trade. (https://ticaret.gov.tr)
The Ministry of Trade states that shareholders must be provided at least 15 days under the board’s decision governing exercise of the right. (https://ticaret.gov.tr)
Potentially. The resolution, applicable corporate rules, treatment of pre-emptive rights, purpose of the increase and compliance with the articles should be examined immediately.
Obtain the meeting call and notification records. Defective notice may become relevant to challenging the resulting corporate resolution depending on the circumstances.
Potentially, where the requirements for interim judicial protection are satisfied. Urgency increases where the new voting structure is about to be used to replace management or approve significant transactions.
It may. Shareholder agreements frequently contain pre-emptive rights, anti-dilution provisions, veto rights or reserved matters. The exact wording must be reviewed.
Potentially. The legal basis, responsible parties, damage and causation must be established. Expert valuation may be necessary where the transaction allegedly transferred economic value.
Generally, appropriate proceedings can be pursued through duly authorized legal representation, subject to the requirements applicable to the specific case.
Dilution can transform a foreign investor from an influential shareholder into a powerless minority investor in a single corporate transaction. The legal issue is not simply whether the ownership percentage decreased, but why the capital increase occurred, whether the shareholder’s rights were respected, who acquired the new shares and whether the transaction served a genuine corporate purpose.
The statutory protection of pre-emptive rights is particularly important. The Ministry of Trade confirms that shareholders generally have the right to acquire newly issued shares proportionately to their existing ownership. Restriction or removal requires justified grounds and at least 60% affirmative approval, while management must explain the reasons for restricting the right and the pricing of the issuance. (https://ticaret.gov.tr)
Foreign investors should also act quickly where dilution changes corporate control. If the newly created majority is already attempting to replace management, transfer assets, approve related-party transactions or further reduce the investor’s position, challenging the capital increase alone may not provide adequate protection.
A coordinated strategy may therefore require challenging corporate resolutions, protecting pre-emptive rights, seeking interim judicial measures, enforcing shareholder-agreement protections, investigating director or controlling-shareholder liability and pursuing compensation for legally recoverable losses.
Fırat Fesih Kaya Law Office assists foreign shareholders, international investors and overseas companies with shareholder dilution disputes, abusive capital increases, pre-emptive rights, minority shareholder protection, shareholder agreement enforcement, corporate-control disputes, general assembly challenges, interim measures, director liability and compensation claims in Turkey.
Phone: +90 312 434 22 22
Mobile: +90 532 769 22 22
Email: info@firatfesihkaya.av.tr
Address: Mevlana Boulevard No: 221, Yıldırım Tower, Balgat, Çankaya, Ankara, Turkey